Article Details

ImmPACT Bio Announces FDA Clearance of IND Application for CD19/CD20 Bispecific CAR ...

Retrieved on: 2024-08-22 13:19:34

Tags for this article:

Click the tags to see associated articles and topics

ImmPACT Bio Announces FDA Clearance of IND Application for CD19/CD20 Bispecific CAR .... View article details on hiswai:

Excerpt

“As an intended one-time treatment, IMPT-514 has the potential to reset the immune system by depleting a broad range of autoreactive immune cells ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up